Black Rock Inc. Legend Biotech Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,721,277 shares of LEGN stock, worth $234 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,721,277
Previous 5,384,030
6.26%
Holding current value
$234 Million
Previous $302 Million
16.09%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$457 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$307 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$272 Million7.41% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$206 Million1.16% of portfolio
-
Invesco Ltd. Atlanta, GA2.29MShares$93.7 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.85B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...